Cargando…

Editorial: Erythropoietin and Its Analogues as Therapeutics for Neurological Diseases

Detalles Bibliográficos
Autores principales:	Brines, Michael, Carelli, Stephana, Samaja, Michele, Schneider Gasser, Edith M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883430/ https://www.ncbi.nlm.nih.gov/pubmed/35237172 http://dx.doi.org/10.3389/fphar.2022.841538

Ejemplares similares

Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases
por: Rey, Federica, et al.
Publicado: (2019)

Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects
por: Rey, Federica, et al.
Publicado: (2021)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021)

Erythropoietin Produces a Dual Effect on Carotid Body Chemoreception in Male Rats
por: Arias-Reyes, Christian, et al.
Publicado: (2021)

Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?
por: Ottolenghi, Sara, et al.
Publicado: (2021)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Erythropoietin: Recent Developments in the Treatment of Spinal Cord Injury
por: Carelli, Stephana, et al.
Publicado: (2011)

Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications
por: Pandini, Cecilia, et al.
Publicado: (2023)

Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets
por: Zhao, Jia, et al.
Publicado: (2023)

Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders
por: Ayaz, Muhammad, et al.
Publicado: (2019)

Editorial: Assessing the Pharmacological Effects and Therapeutic Potential of Traditional Chinese Medicine in Neurological Disease Models: An Update
por: Deng, Zhiqiang, et al.
Publicado: (2022)

Brain adaptation to hypoxia and hyperoxia in mice
por: Terraneo, Laura, et al.
Publicado: (2016)

The therapeutic potential of triptolide and celastrol in neurological diseases
por: Cui, Yueran, et al.
Publicado: (2022)

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
por: Ramsay, Rona R., et al.
Publicado: (2017)

The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review
por: Ma, Yuanyuan, et al.
Publicado: (2022)

Dynamics of Erythroferrone Response to Erythropoietin in Rats
por: Xu, Peng, et al.
Publicado: (2022)

Erythropoietin and Non-Erythropoietic Derivatives in Cognition
por: Newton, Samuel S., et al.
Publicado: (2021)

Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?
por: Coleman, Thomas, et al.
Publicado: (2004)

Erythropoietin Stimulates GABAergic Maturation in the Mouse Hippocampus
por: Khalid, Kasifa, et al.
Publicado: (2021)

Editorial: Metabolic and Neurological Modulation by Glucosinolates, Isothiocyanates, and Terpenes to Improve Health
por: González-Trujano, M. E., et al.
Publicado: (2022)

Editorial: Restoring endoplasmic reticulum proteostasis to treat neurological disorders
por: Medinas, Danilo B., et al.
Publicado: (2023)

Editorial: Neuroinflammation and Its Resolution: From Molecular Mechanisms to Therapeutic Perspectives
por: Zusso, Morena, et al.
Publicado: (2020)

Podoplanin: Its roles and functions in neurological diseases and brain cancers
por: Wang, Yi, et al.
Publicado: (2022)

Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders
por: Cichon, Joseph, et al.
Publicado: (2022)

Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats
por: Nguyen, Ly M., et al.
Publicado: (2018)

Editorial: Neurological, Metabolic and Inflammatory Disorders: A Common Root in Inflammasome
por: Pellegrini, Carolina, et al.
Publicado: (2021)

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
por: Maramai, Samuele, et al.
Publicado: (2016)

Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, volume I
por: Pereira, Marta P., et al.
Publicado: (2022)

Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, Volume II
por: Pereira, Marta P., et al.
Publicado: (2023)

Editorial: New therapeutic targets for human placental angiogenesis disease
por: Escudero, Carlos A.
Publicado: (2014)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
por: Qin, Cheng Xue, et al.
Publicado: (2020)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Therapeutic Implications for Pregnant Women With Systemic Autoimmune Diseases and Their Children
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2021)

Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19
por: Sakkiah, Sugunadevi, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Editorial: Women in pharmacology of infectious diseases: 2021
por: Schneider-Futschik, Elena K., et al.
Publicado: (2022)

Editorial: Therapeutic implications of circadian rhythms
por: Yang, Guangrui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0q36ns83q1ahjoftuui5bi6u8c